Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
disease into specific subclasses. You will develop AI algorithms to train models that predict if individuals (from which we create circuits) are prone to develop disease and to identify conditions that have
-
and Delivery: Design and develop training programs on Data Science and AI topics, including machine learning algorithms, data visualization, and statistical analysis. Provide foundational sessions about
-
innovative technologies. The VIB Technologies comprises multiple state-of-the-art core facilities, each with a specific technology focus and embedded within the VIB centers in Ghent, Leuven, or Brussels
-
, onboarding materials). Foster a security-by-design culture in collaboration with ICT and research units, promoting early engagement in tool development and procurement. Actively engage with stakeholders across
-
). We are particularly interested in recruiting faculty members who use and develop artificial intelligence methods and mechanistic mathematical models to address fundamental questions in biology
-
in A. thaliana and wheat, which we started to functionally characterize. The Vascular Development group (https://www.derybellab.be), studies plant vascular development at the interface between
-
Advanced Grant (2025 – 2030). We have developed in vivo single-cell CRISPR technologies to screen for dozens of molecular factors in liver macrophages in vivo. We will apply these technologies to unravel
-
Saelens team. Research Project In this research project you will develop probabilistic deep-learning models that automatically extract biological and statistical knowledge from in vivo perturbational omics
-
initiative investigating how human-specific features of brain development shape early behavior and neural circuit function in autism spectrum disorders (ASD). This position is a joint effort between the
-
supported by a Foundation against Cancer (2025 – 2030). We have developed in vivo single-cell CRISPR technologies to screen for dozens of molecular factors in tumor-associated macrophages (TAMs) in vivo. We